Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 3/20 | 0.50 |
| ▸ | PARP1 | P09874 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 5/20 | 0.43 |
| ▸ | CASP7 | P55210 | 2/20 | 0.43 |
| ▸ | CASP2 | P42575 | 1/20 | 0.43 |
| ▸ | CASP6 | P55212 | 1/20 | 0.43 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.43 |
| ▸ | STK10 | O94804 | 3/20 | 0.39 |
| ▸ | SLK | Q9H2G2 | 3/20 | 0.39 |
| ▸ | CLK2 | P49760 | 1/20 | 0.39 |
| ▸ | GSK3A | P49840 | 1/20 | 0.39 |
| ▸ | STK33 | Q9BYT3 | 1/20 | 0.39 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.39 |
| ▸ | TLK1 | Q9UKI8 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28099802 | 0.88 | GSK3B (0.50) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL5506330 | 0.87 | MAOA (0.51) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL27553346 | 0.87 | KDM4E (0.41) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL384815 | 0.84 | TOP1 (0.55) | GSK3BKDM4EALDH1A1GAAHPGD | |
| SCHEMBL9768590 | 0.84 | KDM4E (0.51) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL29378366 | 0.84 | TOP1 (0.55) | GSK3BKDM4EALDH1A1GAAHPGD | |
| SCHEMBL16628857 | 0.83 | MAOA (0.41) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL28812042 | 0.83 | MAOA (0.59) | GSK3BHPGDGSK3AMEN1USP2 | |
| SCHEMBL9123193 | 0.81 | GSK3B (0.43) | GSK3BPARP1KDM4EALDH1A1GAA | |
| SCHEMBL9787456 | 0.81 | CXCL8 (0.54) | KDM4EALDH1A1GAAHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10815390-B2 | Polyimide resin composition and varnish produced from terminal-modified imide oligomer prepared using 2-phenyl-4,4′-diaminodiphenyl ether and thermoplastic aromatic polyimide prepared using oxydiphthalic acid, polyimide resin composition molded article and prepreg having excellent heat resistance and mechanical characteristic, and fiber-reinforced composite material thereof | KANEKA CORPORATION (JP) | 2020-10-27 | — | — | US | claimed |
| US-20180273798-A1 | POLYIMIDE RESIN COMPOSITION AND VARNISH PRODUCED FROM TERMINAL-MODIFIED IMIDE OLIGOMER PREPARED USING 2-PHENYL-4,4'-DIAMINODIPHENYL ETHER AND THERMOPLASTIC AROMATIC POLYIMIDE PREPARED USING OXYDIPHTHALIC ACID, POLYIMIDE RESIN COMPOSITION MOLDED ARTICLE AND PREPREG HAVING EXCELLENT HEAT RESISTANCE AND MECHANICAL CHARACTERISTIC, AND FIBER-REINFORCED COMPOSITE MATERIAL THEREOF | KANEKA CORPORATION (JP) | 2018-09-27 | — | — | US | claimed |
| US-10017666-B2 | Polyimide resin composition and varnish produced from terminal-modified imide oligomer prepared using 2-phenyl-4,4′-diaminodiphenyl ether and thermoplastic aromatic polyimide prepared using oxydiphthalic acid, polyimide resin composition molded article and prepreg having excellent heat resistance and mechanical characteristic, and fiber-reinforced composite material thereof | KANEKA CORPORATION (JP) | 2018-07-10 | — | — | US | claimed |
| EP-2995649-B1 | POLYIMIDE RESIN COMPOSITION COMPRISING TERMINAL-MODIFIED IMIDE OLIGOMER PREPARED USING 2-PHENYL-4,4'-DIAMINODIPHENYL ETHER AND AROMATIC THERMOPLASTIC POLYIMIDE PREPARED USING OXYDIPHTHALIC ACID, VARNISH, POLYIMIDE RESIN COMPOSITION MOLDED ARTICLE HAVING EXCELLENT HEAT RESISTANCE AND MECHANICAL PROPERTIES, PREPREG, AND FIBER-REINFORCED COMPOSITE MATERIAL CONTAINING SAID PREPREG | KANEKA CORP (JP) | 2017-11-08 | — | — | EP | claimed |
| US-20160083618-A1 | POLYIMIDE RESIN COMPOSITION AND VARNISH PRODUCED FROM TERMINAL-MODIFIED IMIDE OLIGOMER PREPARED USING 2-PHENYL-4,4'-DIAMINODIPHENYL ETHER AND THERMOPLASTIC AROMATIC POLYIMIDE PREPARED USING OXYDIPHTHALIC ACID, POLYIMIDE RESIN COMPOSITION MOLDED ARTICLE AND PREPREG HAVING EXCELLENT HEAT RESISTANCE AND MECHANICAL CHARACTERISTIC, AND FIBER-REINFORCED COMPOSITE MATERIAL THEREOF | KANEKA CORPORATION (JP) | 2016-03-24 | — | — | US | claimed |
| EP-2995649-A1 | POLYIMIDE RESIN COMPOSITION COMPRISING TERMINAL-MODIFIED IMIDE OLIGOMER PREPARED USING 2-PHENYL-4,4'-DIAMINODIPHENYL ETHER AND AROMATIC THERMOPLASTIC POLYIMIDE PREPARED USING OXYDIPHTHALIC ACID, VARNISH, POLYIMIDE RESIN COMPOSITION MOLDED ARTICLE HAVING EXCELLENT HEAT RESISTANCE AND MECHANICAL PROPERTIES, PREPREG, AND FIBER-REINFORCED COMPOSITE MATERIAL CONTAINING SAID PREPREG | Kaneka Corporation (JP) | 2016-03-16 | — | — | EP | claimed |
| EP-2097375-B1 | METHOD FOR PURIFYING BISIMIDES | SABIC INNOVATIVE PLASTICS IP (NL) | 2013-04-24 | — | — | EP | claimed |
| EP-2097375-A1 | METHOD FOR PURIFYING BISIMIDES | Sabic Innovative Plastics IP B.V. (NL) | 2009-09-09 | — | — | EP | claimed |
| US-7408070-B2 | Method for purifying bisimides | SABIC INNOVATIVE PLASTICS IP B.V. (US) | 2008-08-05 | — | — | US | claimed |
| WO-2008063208-A1 | METHOD FOR PURIFYING BISIMIDES | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-05-29 | — | — | WO | claimed |
| US-20070073063-A1 | Method for purifying bisimides | GENERAL ELECTRIC COMPANY (US) | 2007-03-29 | — | — | US | claimed |
| US-5212261-A | LATENT, HEAT-CURABLE EPOXY RESIN COMPOSITIONS CONTAINING METAL CARBOXYLATE CURING SYSTEMS | HENKEL RESEARCH CORPORATION (US) | 1993-05-18 | — | — | US | claimed |
| WO-1992011307-A1 | LATENT, HEAT-CURABLE EPOXY RESIN COMPOSITIONS CONTAINING METAL CARBOXYLATE CURING SYSTEMS | HENKEL RESEARCH CORPORATION (US) | 1992-07-09 | — | — | WO | claimed |
| EP-0250981-B1 | METHOD FOR MAKING BISIMIDES | GENERAL ELECTRIC COMPANY (US) | 1992-03-11 | — | — | EP | claimed |
| US-4933469-A | Method for preparing oxybisphthalimides | GENERAL ELECTRIC COMPANY (US) | 1990-06-12 | — | — | US | claimed |
| US-4780544-A | HEATING N-ORGANONITROPHTHALIMIDE IN PRESENCE OF APROTIC SOLVENT IN ALKALI METAL CARBOXYLATE | GENERAL ELECTRIC COMPANY (US) | 1988-10-25 | — | — | US | claimed |
| CN-115175951-A | Resin composition, cured product, prepreg, metal foil-clad laminate, resin sheet, and printed wiring board | 三菱瓦斯化学株式会社 | 2022-10-11 | — | — | CN | disclosed |
| US-10815390-B2 | Polyimide resin composition and varnish produced from terminal-modified imide oligomer prepared using 2-phenyl-4,4′-diaminodiphenyl ether and thermoplastic aromatic polyimide prepared using oxydiphthalic acid, polyimide resin composition molded article and prepreg having excellent heat resistance and mechanical characteristic, and fiber-reinforced composite material thereof | KANEKA CORPORATION (JP) | 2020-10-27 | — | — | US | disclosed |
| EP-0264624-A1 | Process for the preparation of oxy-diphthalic anhydrides | OCCIDENTAL CHEMICAL CORPORATION (US) | 1988-04-27 | — | — | EP | disclosed |
| US-4697023-A | HYDROXYLATION OF HALOPHTHALIC ANHYDRIDE, ETHERIFICATION | OCCIDENTAL CHEMICAL CORPORATION (US) | 1987-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070073063-A1 | Method for purifying bisimides | FHIT, PBRM1, TNS4 | GSK3B 4609/4885PARP1 1119/4885KDM4E 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.